Overview

Intranasal Midazolam for Pediatric Pre-procedural Sedation and Pre-procedural Anti-anxiety Using sipNose Device - a Randomized Controlled Study

Status:
Unknown status

Trial end date:
2020-07-01

Target enrollment:

Participant gender:

Summary

A Three-arm, Randomized Controlled Trial for Pediatric Pre-procedural Sedation and Pre-procedural Anti-anxiety: Intranasal Midazolam by SipNose versus MAD Versus oral administration

Phase:

N/A

Details

Lead Sponsor:

Rabin Medical Center

Collaborator:

SipNose

Treatments:

Midazolam